Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (201-210 of 311) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|October 25, 2011
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Rheumatology (Oxford, England)|January 6, 2017
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis RegistryAugustin Latourte, Jacques-Eric Gottenberg, Cécile Luxembourger, et al.
RMD Open|November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndromePilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
La Revue De Medecine Interne|July 15, 2023
French national diagnostic and care protocol for Sjögren's diseaseValérie Devauchelle-Pensec, Xavier Mariette, Anas-Alexis Benyoussef, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2018
Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY TrialsJacques-Eric Gottenberg, Thomas Dörner, Hendrika Bootsma, et al.
RMD Open|February 14, 2018
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patientsFrançois Danion, Laetitia Sparsa, Laurent Arnaud, et al.
RMD Open|March 1, 2024
Characterisation of airway disease associated with Sjögren diseaseLoïc Meudec, Marie-Pierre Debray, Antoine Beurnier, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Joint Bone Spine|November 28, 2021
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR RegistryAdeline Ruyssen-Witrand, Yacine Boudali, Isabelle Pane, et al.
Pageof 32

Showing results (201-210 of 311) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|October 25, 2011
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Rheumatology (Oxford, England)|January 6, 2017
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis RegistryAugustin Latourte, Jacques-Eric Gottenberg, Cécile Luxembourger, et al.
RMD Open|November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndromePilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
La Revue De Medecine Interne|July 15, 2023
French national diagnostic and care protocol for Sjögren's diseaseValérie Devauchelle-Pensec, Xavier Mariette, Anas-Alexis Benyoussef, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2018
Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY TrialsJacques-Eric Gottenberg, Thomas Dörner, Hendrika Bootsma, et al.
RMD Open|February 14, 2018
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patientsFrançois Danion, Laetitia Sparsa, Laurent Arnaud, et al.
RMD Open|March 1, 2024
Characterisation of airway disease associated with Sjögren diseaseLoïc Meudec, Marie-Pierre Debray, Antoine Beurnier, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Joint Bone Spine|November 28, 2021
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR RegistryAdeline Ruyssen-Witrand, Yacine Boudali, Isabelle Pane, et al.
Pageof 32